Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis
Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis and Systemic Lupus Erythematosus
Adicet Bio Announces First Systemic Sclerosis Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
SAGA Metals Achieves 100% Drilling Success in 2025-Reports Final Assays from Trapper South at Radar Critical Minerals Project in Labrador
Domestic Metals Initiates Geophysical Program at the Smart Creek Project and announces non-brokered Private Placement
Nextech3D.ai Expands Krafty Lab Enterprise Engagement Platform with F-35 Flight Simulation Experiences Through The Squadron Partnership
